![]()
benzinga | Nabriva Shares Volatile As Biopharma Updates FDA Filing Timeline |
benzinga | FDA Type A Meetings: What You Need To Know |
yahoo | Rosen, a Top Ranked Law Firm, Announces Filing of Securities Class Action Lawsuit Against Nabriva Therapeutics plc- NBRV |
yahoo | Robbins Arroyo LLP: Nabriva Therapeutics plc Misled Shareholders According to a Recently Filed Lawsuit |
yahoo | Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nabriva Therapeutics plc |
yahoo | NABRIVA DEADLINE ALERT: Rosen Law Firm Reminds Nabriva Therapeutics plc Investors of Important Deadline in the Securities Class Action– NBRV |
yahoo | INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Nabriva Therapeutics plc Investors |
yahoo | IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm |
yahoo | IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm |
yahoo | EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nabriva Therapeutics plc – NBRV |
yahoo | NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm |
yahoo | Glancy Prongay & Murray LLP Announces Investigation on Behalf of Nabriva Therapeutics plc Investors |
yahoo | INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Nabriva Therapeutics plc Investors |
yahoo | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nabriva Therapeutics plc - NBRV |
benzinga | Nabriva Shares Tumble After FDA Issues CRL For Antibiotic Candidate |
bizjournals | Nabriva fails to win FDA approval for experimental antibiotic |
reuters | FDA declines to approve Nabriva's antibiotic for urinary tract infections |
schaeffersresearch | Options Bulls Bet on This Drug Stock to Double |
bizjournals | FDA's decision looming on Nabriva's experimental antibiotic |
prnewswire | Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases |
